报价延迟最少15分钟:2026/06/21 14:06 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.6715 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.67/-0.43
|
|
企业价值
4.45M
|
| 资产负债 |
|
每股账面净值
5.26
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
2.55M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes. |
